SLS SELLAS Life Sciences Group, Inc.

track record → $4.46 -0.18 (-3.9%)
Get emailed when SLS changes direction
Mkt Cap $903M 52wk $1.26 - $6.14 Earnings 2026-05-12
Factor Model (net +1.2)

Factor Model

net +1.2
Est. Revisions
+0.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+1.0
Narrative Gap
+0.0

Analysis pending — waiting for first signal cycle.

Evidence

13d ago Insider buy by KALIN KATHERINE BACH (SLS): $100,806
13d ago Insider buy by VAN NOSTRAND ROBERT L (SLS): $14,800
13d ago Insider buy by WASMAN JANE (SLS): $33,800
13d ago Insider buy by KALIN KATHERINE BACH (SLS): $36,000
Fundamentals & Data ▾
SELLAS Life Sciences Group, Inc. Healthcare · Biotechnology
Mkt Cap
$903M
Beta
2.23
52w Range
$1.26 - $6.14
Short Interest
53.5M 29.98%
Days to Cover
6.5 +9%
Technicals downtrend
from 52w Hi
-14.6%
1w return
-14.6%
Insiders
buying 4B / 0S
EPS Estimate
$-0.06 +0.0% 30d 1up / 0dn
Est. Dispersion
67% 2 analysts
Analyst Target
$10 $10 - $10
Options P/C
0.03
Insider Cluster
strong buy 3B / 0S
Fund Convergence
moderate Citadel, Two Sigma
Top Holders
Citadel $8M
Two Sigma
Recent Filings & Data
insider trade 19
net buying · $185,406 bought
8 insiders · 19 transactions (30d)
Recent transactions
BURNS JOHN THOMAS · award
KALIN KATHERINE BACH · award
VARIAN JOHN W · award
VAN NOSTRAND ROBERT L · award
SCHEINBERG DAVID A · award
WASMAN JANE · award
CICIC DRAGAN · award
KALIN KATHERINE BACH · buy · $100,806
VAN NOSTRAND ROBERT L · buy · $14,800
WASMAN JANE · buy · $33,800
KALIN KATHERINE BACH · buy · $36,000
STERGIOU ANGELOS M · award
KALIN KATHERINE BACH · award
VARIAN JOHN W · award
VAN NOSTRAND ROBERT L · award
SCHEINBERG DAVID A · award
WASMAN JANE · award
CICIC DRAGAN · award
BURNS JOHN THOMAS · award
5 signals · latest 13d ago

Get alerted when SLS changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.